{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:11:35Z","timestamp":1790475095701,"version":"4.1.0"},"reference-count":53,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Maternal infection by Toxoplasma gondii during pregnancy may have serious consequences for the fetus, ranging from miscarriage, central nervous system involvement, retinochoroiditis, or subclinical infection at birth with a risk of late onset of ocular diseases. As infection in pregnant women is usually symptomless, the diagnosis relies only on serological tests. Some countries like France and Austria have organized a regular serological testing of pregnant women, some others have no prenatal program of surveillance. Reasons for these discrepant attitudes are many and debatable. Among them are the efficacy of antenatal treatment and cost-effectiveness of such a program. A significant body of data demonstrated that rapid onset of treatment after maternal infection reduces the risk and severity of fetal infection. Recent cost-effectiveness studies support regular screening. This lack of consensus put both pregnant women and care providers in a difficult situation. Another reason why congenital toxoplasmosis is disregarded in some countries is the lack of precise information about its impact on the population. Precise estimations on the burden of the disease can be achieved by systematic screening that will avoid bias or underreporting of cases and provide a clear view of its outcome.<\/jats:p>","DOI":"10.3390\/pathogens7010025","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T12:41:40Z","timestamp":1519389700000},"page":"25","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Congenital Toxoplasmosis: A Plea for a Neglected Disease"],"prefix":"10.3390","volume":"7","author":[{"given":"Martine","family":"Wallon","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon, Institut de Parasitologie et Mycologie M\u00e9dicale, H\u00f4pital de la Croix Rousse, F-69317 Lyon, France"},{"name":"Waking team, Lyon Neuroscience Research Center, INSERM U1028-CNRS UMR 5292, F-69008 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Peyron","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Institut de Parasitologie et Mycologie M\u00e9dicale, H\u00f4pital de la Croix Rousse, F-69317 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gilbert, R.E., Freeman, K., Lago, E.G., Bahia-Oliveira, L.M.G., Tan, H.K., Wallon, M., Buffolano, W., Stanford, M.R., and Petersen, E. (2008). European Multicentre Study on Congenital Toxoplasmosis (EMSCOT) Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis., 2.","DOI":"10.1371\/journal.pntd.0000277"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3201\/eid1504.081306","article-title":"Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana","volume":"15","author":"Carme","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijpara.2007.09.004","article-title":"Population structure and mouse-virulence of Toxoplasma gondii in Brazil","volume":"38","author":"Pena","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1086\/342663","article-title":"Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings","volume":"186","author":"Ajzenberg","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/civ720","article-title":"Patterns of Hydrocephalus Caused by Congenital Toxoplasma gondii Infection Associate With Parasite Genetics","volume":"61","author":"Hutson","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/INF.0b013e3181c80493","article-title":"In utero and at birth diagnosis of congenital toxoplasmosis: Use of likelihood ratios for clinical management","volume":"29","author":"Rabilloud","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/cid\/cit032","article-title":"Congenital toxoplasma infection: Monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years","volume":"56","author":"Wallon","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thi\u00e9baut, R., Leproust, S., Ch\u00eane, G., and Gilbert, R. (2007). Effectiveness of prenatal treatment for congenital toxoplasmosis: A meta-analysis of individual patients\u2019 data. Lancet Lond. Engl., 369, 115\u2013122.","DOI":"10.1016\/S0140-6736(07)60072-5"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","article-title":"Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling","volume":"353","author":"Dunn","year":"1999","journal-title":"Lancet Lond. Engl."},{"key":"ref_12","first-page":"112","article-title":"Implementation of Screening for Toxoplasma gondii Infection in Pregnancy","volume":"2","author":"Agrappi","year":"2010","journal-title":"J. Clin. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00365540110080386","article-title":"Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women","volume":"34","author":"Logar","year":"2002","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajog.2004.07.031","article-title":"Toxoplasmosis Study Group Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening","volume":"192","author":"Boyer","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_15","unstructured":"World Health Organization (2018, February 15). Principles and Practice of Screening for Disease. Available online: https:\/\/www.google.fr\/search?q=15.+Principles+and+practice+of+screening+for+disease%3B+World+Health+Organization%3A+Geneva%2C+1968%3B&oq=15.+Principles+and+practice+of+screening+for+disease%3B+World+Health+Organization%3A+Geneva%2C+1968%3B&aqs=chrome..69i57.630j0j7&sourceid=chrome&ie=UTF-8."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJMcp0901926","article-title":"Clinical practice. Screening for ovarian cancer","volume":"361","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_17","unstructured":"Tourdjman, M., Tch\u00e9andjieu, C., De Valk, H., Goulet, V., and Le Strat, Y. (2018, February 15). Toxoplasmose chez les Femmes Enceintes en France\u202f: \u00c9volution de la S\u00e9ropr\u00e9valence et des Facteurs Associ\u00e9s Entre 1995 et 2010, \u00e0 Partir des Enqu\u00eates Nationales P\u00e9rinatales. [Toxoplasmosis among Pregnant Women in France: Trends in Seroprevalence and Associated Factors between 1995 and 2010]. Available online: http:\/\/opac.invs.sante.fr\/doc_num.php?explnum_id=10001."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4269\/ajtmh.14-0013","article-title":"Toxoplasma gondii seroprevalence in the United States 2009\u20132010 and comparison with the past two decades","volume":"90","author":"Jones","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_19","first-page":"59","article-title":"Preventing congenital toxoplasmosis","volume":"49","author":"Lopez","year":"2000","journal-title":"MMWR Recomm. Rep. Morb. Mortal. Wkly. Rep. Recomm. Rep. Cent. Dis. Control"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"Pappas","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/501362","article-title":"Time to screen for congenital toxoplasmosis?","volume":"42","author":"Kim","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMp1709816","article-title":"Evidence-Based Health Policy","volume":"377","author":"Baicker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/cid\/cis234","article-title":"Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy","volume":"54","author":"Hotop","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/INF.0b013e318134286d","article-title":"Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis","volume":"27","author":"Kieffer","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1093\/cid\/ciu724","article-title":"The Austrian Toxoplasmosis Register, 1992\u20132008","volume":"60","author":"Prusa","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cortina-Borja, M., Tan, H.K., Wallon, M., Paul, M., Prusa, A., Buffolano, W., Malm, G., Salt, A., Freeman, K., and Petersen, E. (2010). European Multicentre Study on Congenital Toxoplasmosis (EMSCOT) Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: An observational prospective cohort study. PLoS Med., 7.","DOI":"10.1371\/journal.pmed.1000351"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1651-2227.2005.tb01844.x","article-title":"Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centres","volume":"94","author":"Gras","year":"2005","journal-title":"Acta Paediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/cid\/civ1035","article-title":"Effect of Antenatal Treatment on the Severity of Congenital Toxoplasmosis","volume":"62","author":"Wallon","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","unstructured":"Peyron, F., Wallon, M., Kieffer, F., and Garweg, J. (2016). Toxoplasmosis. Infectious Diseases of the Fetus and the Newborn Infant, Elsevier. Available online: https:\/\/books.google.fr\/books?id=VuZ1BwAAQBAJ&pg=PR3&dq=remington+and+klein%27s&hl=fr&sa=X&ved=0ahUKEwj1-4nF1LrZAhWF0RQKHUaMDKIQ6AEIKzAA#v=onepage&q=remington%20and%20klein%27s&f=false."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ben-Harari, R.R., Goodwin, E., and Casoy, J. (2017). Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review. Drugs RD.","DOI":"10.1007\/s40268-017-0206-8"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Maldonado, Y.A., and Read, J.S. (2017). Committee on Infectious Diseases Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics, 139.","DOI":"10.1542\/peds.2016-3860"},{"key":"ref_32","unstructured":"Foodborne Disease Burden Epidemiology Reference Group (FERG) 2007\u20132015 (2018, February 15). WHO Estimates of the Global Burden of Foodborne Diseases. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/199350\/1\/9789241565165_eng.pdf."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Nissen, J., Jokelainen, P., Stensvold, C.R., Trevisan, C., Fuchs, J., Burgdorf, K.S., Nielsen, H.V., and Pires, S.M. (2017). The disease burden of congenital toxoplasmosis in Denmark, 2014. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178282"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Van Lier, A., McDonald, S.A., Bouwknegt, M., EPI group, Kretzschmar, M.E., Havelaar, A.H., Mangen, M.-J.J., Wallinga, J., and de Melker, H.E. (2016). Disease Burden of 32 Infectious Diseases in the Netherlands, 2007\u20132011. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153106"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00003081-199903000-00020","article-title":"Is routine antenatal toxoplasmosis screening justified in the United States? Statistical considerations in the application of medical screening tests","volume":"42","author":"Mittendorf","year":"1999","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Stillwaggon, E., Carrier, C.S., Sautter, M., and McLeod, R. (2011). Maternal serologic screening to prevent congenital toxoplasmosis: A decision-analytic economic model. PLoS Negl. Trop. Dis., 5.","DOI":"10.1371\/journal.pntd.0001333"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Prusa, A.-R., Kasper, D.C., Sawers, L., Walter, E., Hayde, M., and Stillwaggon, E. (2017). Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005648"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cca.2016.10.023","article-title":"Evaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgM","volume":"464","author":"Chapey","year":"2017","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Begeman, I.J., Lykins, J., Zhou, Y., Lai, B.S., Levigne, P., El Bissati, K., Boyer, K., Withers, S., Clouser, F., and Noble, A.G. (2017). Point-of-care testing for Toxoplasma gondii IgG\/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005670"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10096-006-0204-1","article-title":"Delayed maturation of immunoglobulin G avidity: Implication for the diagnosis of toxoplasmosis in pregnant women","volume":"25","author":"Wallon","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"De Oliveira Azevedo, C.T., do Brasil, P.E.A.A., Guida, L., and Lopes Moreira, M.E. (2016). Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149938"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e3181d57b09","article-title":"Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid","volume":"115","author":"Wallon","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1148\/radiol.2017171238","article-title":"How Does Imaging of Congenital Zika Compare with Imaging of Other TORCH Infections?","volume":"285","author":"Levine","year":"2017","journal-title":"Radiology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Pereboom, M.T.R., Manni\u00ebn, J., Spelten, E.R., Schellevis, F.G., and Hutton, E.K. (2013). Observational study to assess pregnant women\u2019s knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus. BMC Preg. Childbirth, 13.","DOI":"10.1186\/1471-2393-13-98"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/501360","article-title":"Toxoplasmosis Study Group Outcome of treatment for congenital toxoplasmosis, 1981\u20132004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wallon, M., Garweg, J.G., Abrahamowicz, M., Cornu, C., Vinault, S., Quantin, C., Bonithon-Kopp, C., Picot, S., Peyron, F., and Binquet, C. (2014). Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Pediatrics, 133.","DOI":"10.1542\/peds.2013-2153"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/INF.0b013e31820bb5f3","article-title":"Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance","volume":"30","author":"Peyron","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pt.2013.01.007","article-title":"How and why Toxoplasma makes us crazy","volume":"29","author":"Flegr","year":"2013","journal-title":"Trends Parasitol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Del Grande, C., Galli, L., Schiavi, E., Dell\u2019Osso, L., and Bruschi, F. (2017). Is Toxoplasma gondii a Trigger of Bipolar Disorder?. Pathog. Basel Switz., 6.","DOI":"10.3390\/pathogens6010003"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Peyron, F., Mc Leod, R., Ajzenberg, D., Contopoulos-Ioannidis, D., Kieffer, F., Mandelbrot, L., Sibley, L.D., Pelloux, H., Villena, I., and Wallon, M. (2017). Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005222"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJMp0911938","article-title":"Untangling the Web--patients, doctors, and the Internet","volume":"362","author":"Hartzband","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1067\/mob.2001.108341","article-title":"Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers","volume":"184","author":"Liesenfeld","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/cid\/cix344","article-title":"Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis","volume":"65","author":"Smit","year":"2017","journal-title":"Clin. Infect. Dis."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/7\/1\/25\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:56:05Z","timestamp":1760194565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/7\/1\/25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["pathogens7010025"],"URL":"https:\/\/doi.org\/10.3390\/pathogens7010025","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]}}}